TY  - JOUR
TI  - Antibiotic Use among Patients Hospitalized  with COVID-19 and Treated in Three  Different Clinics
AB  - Objective: In this study, we aimed to determine and compare the rates of empirical antibiotic use and duration between the chest diseases clinic (CDC), infectious disease clinic (IDC), and internal medicine clinic (IMC) among patients hospitalized because of COVID-19. Methods: This cross-sectional study was performed in a single university hospital. The study included all patients aged 18 years and older hospitalized with a PCR-confirmed COVID-19 between May 30, 2021, and August 30, 2021. Clinical and laboratory findings were recorded from the electronic medical records database. Results: The study included a total of 581 inpatients, of whom 310 (53.4%) were women. Of the 581 patients, 475 (81.8%) were prescribed antibiotics. The rate of antibiotic prescription was 71.6% for IDC, 88.5% for CDC, and 87.4% for IMC. The most commonly used antibiotic was moxifloxacin in all groups. The mean treatment duration was 8.9±6.16 days. The mean  duration of antibiotic treatment was 11.1±5.90 days for CDC, 11.3±6.74 days for IMC, and 5.3 days±3.76 for IDC.  Conclusion: Patients with COVID-19 who were treated in IDC had a lower rate and shorter duration of antibiotic use compared to the other clinics. However, the rate of antibiotic prescription in all three groups was very high. Therefore, antimicrobial management programs should be meticulously conducted to reduce unnecessary antibiotic use.
AU  - evlice, oğuz
AU  - ŞENER, Aziz
AU  - Ak, Oznur
AU  - Kaya, Ilknur
AU  - Acet, Aycan
AU  - ARIK, ÖZLEM
AU  - MISTANOGLU OZATAG, DURU
AU  - marım, feride
AU  - BEKTAS, MURAT
DO  - 10.36519/idcm.2022.170
PY  - 2022
JO  - Infectious diseases and clinical microbiology (Online)
VL  - 4
IS  - 3
SN  - 2667-646X
SP  - 199
EP  - 205
DB  - TRDizin
UR  - http://search/yayin/detay/1134827
ER  -